Aigen Investment Management, LP Vericel Corp Transaction History

Aigen Investment Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$30.85 - $37.09 $20,576 - $24,739	667 Added 8.71%	8,326 $296,000
Q3 2023 Nov 13, 2023	BUY	$31.69 - $39.25 $242,713 - $300,615	7,659 New	7,659 $256,000
Q4 2020 Feb 12, 2021	SELL	$18.53 - $31.5 $11,006 - $18,711	-594 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$14.68 - $19.12 $165,942 - $216,132	-11,304 Reduced 95.01%	594 $11,000
Q2 2020 Aug 10, 2020	BUY	$8.5 - $15.82 $101,133 - $188,226	11,898 New	11,898 $164,000

291

50.7M

98.2K

135K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.45B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.